Literature DB >> 8004878

New drug development in the United States from 1963 to 1992.

J A DiMasi1, M A Seibring, L Lasagna.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8004878     DOI： 10.1038/clpt.1994.78

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

Review 1.  The US orphan drug programme 1983-1995.

Authors:  S R Shulman; M Manocchia
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981

Review 2.  The effect of pharmacoeconomics on company research and development decisions.

Authors:  H Grabowski
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

3.  Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

Authors:  J A DiMasi; R W Hansen; H G Grabowski; L Lasagna
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

4.  Computational drug repositioning using meta-path-based semantic network analysis.

Authors:  Zhen Tian; Zhixia Teng; Shuang Cheng; Maozu Guo
Journal:  BMC Syst Biol       Date:  2018-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.